FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2949084530> ?p ?o ?g. }

• W2949084530 abstract "Background: Primary Sjogren’s syndrome (pSS) is an autoimmune disease with the autoantibodies overproduction, including rheumatoid factors (RF). An association of RFs with the disease activity has been already described, with RFs in IgA, IgG immunoglobulin classes suggested as potential biomarkers of immunological/clinical pSS features. Objectives: Examining correlations of RF in IgM, IgA and IgG immunoglobulin classes with other autoantibodies, dry eye tests and histopathological assessment (focus score) of salivary gland inflammation. Methods: We studied 76 patients, mean age 53 (SD=13); (67Female/9Male) with pSS diagnosis (criteria ACR/Eular 2017); mean disease duration from diagnosis 2,24 year. Laboratory tests performed: ESR, C-reactive protein(CRP), concentrations of gamma globulins (g/dl), RF serum concentration assessed using ImmuLisa Enhanced™ RF IgA, IgG, IgM Antibody ELISA IMMCO Diagnostics, Inc. As positive result of the RF-IgA and RF-IgG concentration > 25 EU/mL was considered, as positive RF-IgM > 12,5 EU/mL; a highly positive result set as > 100 EU/mL. Anti-Ro/SSA, and anti-La/SSB antibodies were detected by semiquantitative dot blot method. The eye dryness and keratoconjunctivitis sicca were confirmed with Schirmer’s test (score of less than 5 mm/5’) and the ocular staining score (OSS) using lissamine green and fluorescein staining and biopsy of minor salivary gland with the histopathological evaluation (focus score-FS). The study was approved by the proper ethics committee. Differences between groups were analyzed with U Mann-Whitney test (continuous variables). Correlations between quantative variables were assessed with the Spearman correlation coefficient. Statistical significance was set at p Results: The detection of RF in examined sera: RF- IgA: positive(+) 66% (n=50), negative (-) 34%(n=26); highly positive (++) 51%(n=39); RF-IgG: + 55% (n=42), - 45%(n=34), ++ 9% (n=7); RF-IgM: + 88% (n=67), - 12%(n=9), ++ 55% (n=42). In comparison of patients’ groups: i/RF-IgA (+) vs. RF-IgA(-) : no difference in term of FS, OSS and Schirmer’s test; in RF-IgA(+) group significantly higher anti SS-A antibodies (p=0,002); a significant difference in anti SS-A antibodies level (p=0.028) RF-IgA(++) and lower positive group (less than 100EU/mL); ii/RF-IgM(+) vs. RF-IgM(-): RF-IgM (+) significantly higher anti -SS-A antibodies (p=0.007); iii/RF-IgG (+) vs. RF-IgG(-): RF-IgG(+): RF-IgG(+) significantly higher anti SS-B antibodies (p=0.015). Positive correlation was found between: RF-IgA(+) and RF- IgG(+) (rho=0.647) and RF- IgM(+) (rho= 0.669); RF-IgG(+) and RF-IgM(-) (rho=0.429). Surprisingly no correlations found in studied group between concentrations of RF- IgA, IgG and IgM and WBC, C4, C3 complement component, FS, OSS, and Schirmer’s test. Conclusion: 1. rheumatoid factors in main three classes of gammaglobulins, particularly RF-IgA, strongly associate with anti-SSA and anti-SSB autoantibodies production. 2. RF – IgM and RF- IgA dominate over RF- IgG in pSS. 3. both RF-IgA and RF-IgM may be used as diagnostic tool for pSS. 4. Further research is needed to distinguish activity and role of RF- IgA based upon its presence in serum vs. in saliva. References: [1] Peen E, Mellbye OJ, Haga HJ. IgA rheumatoid factor in primary Sjogren’s syndrome. Scand J Rheumatol. 2009 Jan-Feb;38(1):46-9. [2] Garcia-Carrasco M, Mendoza-Pinto C, Jimenez-Hernandez C, Jimenez-Hernandez M, Nava-Zavala A, Riebeling C. Serologic features of primary Sjogren’s syndrome: clinical and prognostic correlation. Int J Clin Rheumatol. 2012;7(6):651-659. Disclosure of Interests: None declared" @default.
• W2949084530 created "2019-06-27" @default.
• W2949084530 creator A5003374713 @default.
• W2949084530 creator A5019923584 @default.
• W2949084530 creator A5026937868 @default.
• W2949084530 creator A5059265379 @default.
• W2949084530 creator A5062830143 @default.
• W2949084530 creator A5074842598 @default.
• W2949084530 date "2019-06-01" @default.
• W2949084530 modified "2023-09-26" @default.
• W2949084530 title "FRI0245 RHEUMATOID FACTOR IN IGA, IGG AND IGM IMMUNOGLOBULIN CLASES IN PRIMARY SJöGREN’S SYNDROME" @default.
• W2949084530 cites W2064954370 @default.
• W2949084530 cites W2126742402 @default.
• W2949084530 doi "https://doi.org/10.1136/annrheumdis-2019-eular.6365" @default.
• W2949084530 hasPublicationYear "2019" @default.
• W2949084530 type Work @default.
• W2949084530 sameAs 2949084530 @default.
• W2949084530 citedByCount "0" @default.
• W2949084530 crossrefType "proceedings-article" @default.
• W2949084530 hasAuthorship W2949084530A5003374713 @default.
• W2949084530 hasAuthorship W2949084530A5019923584 @default.
• W2949084530 hasAuthorship W2949084530A5026937868 @default.
• W2949084530 hasAuthorship W2949084530A5059265379 @default.
• W2949084530 hasAuthorship W2949084530A5062830143 @default.
• W2949084530 hasAuthorship W2949084530A5074842598 @default.
• W2949084530 hasBestOaLocation W29490845301 @default.
• W2949084530 hasConcept C126322002 @default.
• W2949084530 hasConcept C142724271 @default.
• W2949084530 hasConcept C159654299 @default.
• W2949084530 hasConcept C163764329 @default.
• W2949084530 hasConcept C203014093 @default.
• W2949084530 hasConcept C2776232647 @default.
• W2949084530 hasConcept C2776553844 @default.
• W2949084530 hasConcept C2777575956 @default.
• W2949084530 hasConcept C2779075594 @default.
• W2949084530 hasConcept C2779102806 @default.
• W2949084530 hasConcept C2779134260 @default.
• W2949084530 hasConcept C2780898057 @default.
• W2949084530 hasConcept C2908795448 @default.
• W2949084530 hasConcept C71924100 @default.
• W2949084530 hasConcept C90924648 @default.
• W2949084530 hasConceptScore W2949084530C126322002 @default.
• W2949084530 hasConceptScore W2949084530C142724271 @default.
• W2949084530 hasConceptScore W2949084530C159654299 @default.
• W2949084530 hasConceptScore W2949084530C163764329 @default.
• W2949084530 hasConceptScore W2949084530C203014093 @default.
• W2949084530 hasConceptScore W2949084530C2776232647 @default.
• W2949084530 hasConceptScore W2949084530C2776553844 @default.
• W2949084530 hasConceptScore W2949084530C2777575956 @default.
• W2949084530 hasConceptScore W2949084530C2779075594 @default.
• W2949084530 hasConceptScore W2949084530C2779102806 @default.
• W2949084530 hasConceptScore W2949084530C2779134260 @default.
• W2949084530 hasConceptScore W2949084530C2780898057 @default.
• W2949084530 hasConceptScore W2949084530C2908795448 @default.
• W2949084530 hasConceptScore W2949084530C71924100 @default.
• W2949084530 hasConceptScore W2949084530C90924648 @default.
• W2949084530 hasLocation W29490845301 @default.
• W2949084530 hasOpenAccess W2949084530 @default.
• W2949084530 hasPrimaryLocation W29490845301 @default.
• W2949084530 hasRelatedWork W1145477128 @default.
• W2949084530 hasRelatedWork W1476401690 @default.
• W2949084530 hasRelatedWork W181280242 @default.
• W2949084530 hasRelatedWork W2028851067 @default.
• W2949084530 hasRelatedWork W2079003564 @default.
• W2949084530 hasRelatedWork W2107511640 @default.
• W2949084530 hasRelatedWork W2161908819 @default.
• W2949084530 hasRelatedWork W2171343303 @default.
• W2949084530 hasRelatedWork W2414694676 @default.
• W2949084530 hasRelatedWork W2415011029 @default.
• W2949084530 hasRelatedWork W2416866019 @default.
• W2949084530 hasRelatedWork W2418372180 @default.
• W2949084530 hasRelatedWork W2418995799 @default.
• W2949084530 hasRelatedWork W2427147639 @default.
• W2949084530 hasRelatedWork W2432103841 @default.
• W2949084530 hasRelatedWork W2437491732 @default.
• W2949084530 hasRelatedWork W2560412673 @default.
• W2949084530 hasRelatedWork W93084618 @default.
• W2949084530 hasRelatedWork W179616241 @default.
• W2949084530 hasRelatedWork W2186724347 @default.
• W2949084530 isParatext "false" @default.
• W2949084530 isRetracted "false" @default.
• W2949084530 magId "2949084530" @default.
• W2949084530 workType "article" @default.